Advertisement

Topics

COSMIX molecular biologicals GmbH Company Profile

21:27 EDT 23rd September 2018 | BioPortfolio

COSMIX identifies and improves peptides for applications in healthcare, research, and industry. Peptides are high potential product candidates and well characterized in many applications.
COSMIX’s strong and unique technology platforms enable the generation of innovative, tailored peptide products.

Location

Inhoffenstrasse 7
Braunschweig
D-38124
Germany

Contact

Phone: 49 (0)531-120 86-0
Fax: 49 (0)531-120 86-99
Email: info@cosmix.de


News Articles [697 Associated News Articles listed on BioPortfolio]

FDA approach to retrospectively naming biologicals

How the US Food and Drug Administration’s (FDA) is tackling retrospective naming of biologicals was an issue covered by Dr Kellie Taylor, Associate Director of the Office of Medication Error Prevent...

LenioBio GmbH and Fraunhofer IME to Advance Novel Protein Discoveries Through a License Agreement

DUSSELDORF and AACHEN, Germany, August 1, 2018 /PRNewswire/ -- Life sciences startup LenioBio GmbH and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME Read more...

TGA proposes changes to biologicals regulations

Australia’s drug regulatory agency, the Therapeutic Goods Administration (TGA) announced on 20 April 2018 the release of proposed amendments to its biologicals regulations that are set to take effec...

FDA issues guidance for labelling biologicals and biosimilars

The US Food and Drug Administration (FDA) has issued two new guidance documents that provide recommendations to industry on labelling requirements for biologicals and biosimilars.

Regulation of biologicals in Colombia

Since the introduction of Decree 1782 Colombia has been moving towards a new regulatory landscape for biologicals (productos bioterapéuticos) and similar biotherapeutic products (productos bioterape...

WuXi Biologics expands its biologicals manufacturing facilities

China-based WuXi Biologics, headquartered in Wuxi city of Jiangsu Province, is expanding its biologicals manufacturing capacity with new facilities planned in Ireland, China, Singapore and the US.

Follow-on biologicals and extrapolation in Brazil

Researchers from Brazil discuss the country’s approach to follow-on biologicals and extrapolation of indications in the country [1].

FDA approach to prospectively naming biologicals

During her presentation at the Drug Information Association’s (DIA) Biosimilars Conference, Dr Kellie Taylor, Associate Director of the Office of Medication Error Prevention and Risk Management in t...

PubMed Articles [638 Associated PubMed Articles listed on BioPortfolio]

The analgesic potential of cytokine neutralization with biologicals.

Many acute and chronic inflammatory diseases, cancer and neuropathic disorders are accompanied by severe pain states reducing drastically the life quality of the patients. Biologicals which preferenti...

A large single hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents.

Large-scale studies of Drug Provocation Testing (DPT) or Rapid Drug Desensitization (RDD) for hypersensitivity to antineoplastics and biologicals are scarce and limited to a few institutions OBJECTIVE...

Growth Failure in Children with Systemic Juvenile Idiopathic Arthritis and Prolonged Inflammation despite Treatment with Biologicals: Late Normalization of Height by Combined Hormonal Therapies.

Biologicals targeting the interleukin (IL)-1β or IL-6 pathway are becoming prime choices for the treatment of children with systemic juvenile idiopathic arthritis (sJIA). Up to 1 in 3 sJIA children r...

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Clinical Trials [1630 Associated Clinical Trials listed on BioPortfolio]

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

The purpose of this observer-blind study is to generate immunogenicity data with one formulation of GSK Biologicals' DTPw-HBV/Hib vaccine after the primary vaccination course and to demons...

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

The purpose of this Phase II study is to evaluate the feasibility of GSK Biologicals' GSK2197870A vaccine co-administered with Wyeth-Lederle's Prevenar™ when given in healthy infants as ...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

The purpose of this study is to evaluate the safety and immunogenicity of 2 formulations of GSK Biologicals' varicella vaccines given as a 2-dose course in the second year of life.

Companies [1411 Associated Companies listed on BioPortfolio]

COSMIX molecular biologicals GmbH

COSMIX identifies and improves peptides for applications in healthcare, research, and industry. Peptides are high potential product candidates and well characterized in many applications.COSMIX’s st...

sterna biologicals GmbH & Co. KG

MicroDiscovery GmbH

Based in Berlin, MicroDiscovery GmbH is a leading supplier of bioinformatics solutions in the field of functional genomics. Launched in 2000 as a spin-off from the Max Planck Institute for Molecular G...

Fermentas GmbH

FERMENTAS is a world leader in the discovery, manufacturing and marketing of quality molecular biologicals and providing services to the international research community. As a dynamically evolving bio...

Cosmix

Phage-display based services including custom mouse Fab antibodies

More Information about "COSMIX molecular biologicals GmbH" on BioPortfolio

We have published hundreds of COSMIX molecular biologicals GmbH news stories on BioPortfolio along with dozens of COSMIX molecular biologicals GmbH Clinical Trials and PubMed Articles about COSMIX molecular biologicals GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of COSMIX molecular biologicals GmbH Companies in our database. You can also find out about relevant COSMIX molecular biologicals GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record